Osteonecrosis of the jaw, a recently recognized sequela of bisphosphonate therapy: Case report

Supportive Cancer Therapy

Volumn 3, Issue 2, 2006, Pages 122-124

  Langer, Corey J ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Bone pain; Chemoradiation therapy; Necrotic bone; Pallative therapy; Pamidronate; Zoledronic acid

Indexed keywords

AMOXICILLIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FULVESTRANT; PAMIDRONIC ACID;

ADULT; ANAMNESIS; ARTICLE; BONE METASTASIS; BONE NECROSIS; BONE PAIN; BONE SCINTISCANNING; BREAST CARCINOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; JAW DISEASE; ORAL BIOPSY; PHYSICAL EXAMINATION;

EID: 33645983335     PISSN: 15432912     EISSN: None     Source Type: Journal    
DOI: 10.3816/SCT.2006.n.008     Document Type: Article

References (14)

1. Studer G, Gratz KW, Glanzmann C. Osteoradionecrosis of the mandibula in patients treated with different fractionations. Strahlenther Onkol 2004; 180:233-240.
2. Hunter SE, Scher RL. Clinical implications of radionecrosis to the head and neck surgeon. Curr Opin Otolaryngol Head Neck Surg 2003; 11:103-106.
3. Assael LA. New foundations in understanding osteonecrosis of the jaw. J Oral Maxillofac Surg 2004; 62:125-126.
4. Expert panel recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaws. Hanover, NJ: Novartis; June 2004.
5. Migliorati CA. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 2003; 21:4253-4254.
6. Ruggiero SL, Mehrotta B, Rosenberg TJ, et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004; 62:527-534.
7. Estilo CL. Osteonecrosis of the maxilla and mandible in patients treated with bisphosphonates: a retrospective study. J Clin Oncol 2004; 22:8088.
8. Zometa® [Package insert]. Hanover, NJ: Novartis; 2004.
9. Mashiba T, Turner CH, Hirano T, et al. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 2001; 28:524-531.
10. Fournier P, Boisser S, Filleur S, et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 2002; 62:6538-6544.
11. Li J, Mori S, Kaji Y, et al. Effect of bisphosphonates (incadronate) on fracture healing of long bone in rats. J Bone Miner Res 1999; 14:969-979.
12. Wood J. Novel antiangiogenic effects of the bisphosphonates compound zoledronic acid. J Pharmacol Exp Ther 2002; 302:1055-1061.
13. Kapitola J, Zak J, Lacinova Z, et al. Effect of growth hormone and pamidronate on bone blood flow in oophorectomized rats. Physiol Res 1998; 47:237-240.
14. Kapitola J, Zak J, Lacinova Z, et al. Effect of growth hormone and pamidronate on bone blood flow, bone mineral and IGF-I levels in the rat. Physiol Res 2000; 49(suppl 1):S101-S106.